Popular Articles

Testosterone Replacement For Men With Low Testosterone Improves Liver Function, Metabolic Syndrome
In middle-aged and older men with low testosterone levels, long-term testosterone replacement therapy greatly improves their fatty liver disease and their risk factors for cardiovascular disease and diabetes, a new study found. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
pharmacy online
Media Looks At County-Level HIV, AIDS Map Data
Major population centers such as those in New York and California have the highest numbers of HIV cases, however, many of the areas that have the highest rates of people with HIV are in the South, according to data from an online mapping tool launched by the National Minority Quality Forum yesterday, the AP/Minneapolis Star Tribune reports. The map, which is the first tool of its kind to look at HIV and AIDS cases on a county level, is based on 2006 data collected from states and cross-checked with CDC data. According to the mapping tool, of the 48 counties with the highest HIV prevalence rates, 25 are in Georgia. In addition, Florida, Georgia, South Carolina and Virginia have the highest prevalence rates for HIV cases that have progressed to AIDS (Stobbe, AP/Minneapolis Star Tribune, 6/22). In Virginia, Richmond, Petersburg and Norfolk were among the nation"s urban areas hardest hit by HIV/AIDS (Smith, Richmond Times-Dispatch, 6/23). Three metro counties in Kansas City, Mo., have HIV and AIDS rates that are higher than about 80 percent of counties nationwide, according to the data, NBC Action News reports (Ptacek, NBC Action News, 6/22).
News of the day
Skin-like Tissue Developed From Human Embryonic Stem Cells
Dental and tissue engineering researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have harnessed the pluripotency of human embryonic stem cells (hESC) to generate complex, multilayer tissues that mimic human skin and the oral mucosa (the moist tissue that lines the inside of the mouth). The proof-of-concept study is published online in advance of print in Tissue Engineering Part A.
Health Insurance

The New York Stem Cell Foundation Praises Final NIH Guidelines On Stem Cell Research

The New York Stem Cell Foundation (NYSCF) praised the National Institutes of Health (NIH) Final Guidelines for Human Stem Cell Research that were issued today. Susan L. Solomon, NYSCF CEO, applauded the NIH for listening carefully to the public response to its earlier draft guidelines and its willingness to make modifications in furtherance of stem cell science. "We are pleased that the NIH guidelines issued today provide a way in which funding may be considered for existing stem cell lines, on which current research is being done. President Barack Obama"s leadership on this issue, which will impact generations to come, is to be applauded." "The establishment of the stem cell registry is very important, as is the fact that much of the prescriptive language has been made more flexible," noted Kevin C. Eggan, NYSCF Chief Scientific Officer. "I remain disappointed, however, that somatic cell nuclear transfer (SCNT) and parthenogenesis derived cell lines are not eligible for federal funding and that stem cells derived from embryos created for research are also excluded. We look forward to continuing a dialogue in these areas, for the improvement of scientific advancement." "The NIH guidelines are clear, thoughtful and comprehensive - an extraordinary result, given this huge undertaking, the complexity of the issue, and the magnitude of interest from the scientific community, advocacy groups, medical organizations, and private citizens," said Zach Hall, Ph.D., a NYSCF Board Member, and former Director of the National Institute of Neurological Disorders and Stroke. "The NIH handled the guideline review process with the care and attention that the vital issue of stem cell research deserves." Solomon added, "Today"s announcement is a major step forward and we are grateful to the NIH for its efforts. We hope that the NIH and other federal policy entities will continue to foster discussion so that additional guidelines will be inclusive of all promising avenues of current research, including the creation of disease- and patient-specific human embryonic stem cell lines." The New York Stem Cell Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):